 Connection
Wells Messersmith to Methylurea Compounds
This is a "connection" page, showing publications Wells Messersmith has written about Methylurea Compounds.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.397 |
|
|
|
-
Messersmith WA, Rudek MA, Baker SD, Zhao M, Collins C, Colevas AD, Donehower RC, Carducci MA, Wolff AC. Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours. Eur J Cancer. 2007 Jan; 43(1):78-86.
Score: 0.271
-
Rudek MA, Zhao M, Smith NF, Robey RW, He P, Hallur G, Khan S, Hidalgo M, Jimeno A, Colevas AD, Messersmith WA, Wolff AC, Baker SD. In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent. Clin Cancer Res. 2005 Dec 01; 11(23):8503-11.
Score: 0.063
-
Rudek MA, Zhao M, He P, Zabelina Y, Jin R, Messersmith WA, Wolff AC, Baker SD. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 15; 828(1-2):41-54.
Score: 0.063
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|